Related references
Note: Only part of the references are listed.A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
Sharon B Wigal et al.
Child and Adolescent Psychiatry and Mental Health (2012)
Animal models to guide clinical drug development in ADHD: lost in translation?
Jeffery R. Wickens et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate A Randomized, Open-Label, Two-Period, Crossover, Single-Dose, Single-Centre Pharmacokinetic Study in Healthy Adult Men
James C. Ermer et al.
CLINICAL DRUG INVESTIGATION (2011)
Cost of disorders of the brain in Europe 2010
Anders Gustavsson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H. U. Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Regulation of monoamine transporters: Role of transporter phosphorylation
Sammanda Ramamoorthy et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
Sharon B Wigal et al.
Child and Adolescent Psychiatry and Mental Health (2011)
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design
Timothy Wigal et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2010)
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD
Sandra J. J. Kooij et al.
BMC PSYCHIATRY (2010)
Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults
Gregory Mattingly
CNS SPECTRUMS (2010)
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
Stephen V. Faraone et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2010)
Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD
Rachel E. Dew et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Lisdexamfetamine Dimesylate: Linear Dose-Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open-Label Single-Dose Pharmacokinetic Study in Healthy Adult Volunteers
James Ermer et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Monoaminergic Psychomotor Stimulants: Discriminative Stimulus Effects and Dopamine Efflux
Rajeev I. Desai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
Pennick
Neuropsychiatric Disease and Treatment (2010)
The Efficacy and Safety Profile of Lisdexamfetamine Dimesylate, a Prodrug of d-Amphetamine, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adults
Jadwiga Najib
CLINICAL THERAPEUTICS (2009)
Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
Richard Weisler et al.
CNS SPECTRUMS (2009)
Safety of stimulant treatment in attention deficit hyperactivity disorder: part I
Richard Lawrence Merkel et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder
Lenard A. Adler et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers
D. R. Jasinski et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse
D. R. Jasinski et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters
S. D. Robertson et al.
MOLECULAR NEUROBIOLOGY (2009)
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
D. J. Heal et al.
NEUROPHARMACOLOGY (2009)
The spontaneously hypertensive rat model of ADHD - The importance of selecting the appropriate reference strain
Terje Sagvolden et al.
NEUROPHARMACOLOGY (2009)
Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications
Annette E. Fleckenstein et al.
NEUROPHARMACOLOGY (2009)
America's first amphetamine epidemic 1929-1971 - A quantitative and qualitative retrospective with implications for the present
Nicolas Rasmussen
AMERICAN JOURNAL OF PUBLIC HEALTH (2008)
Metabolism, Distribution and Elimination of Lisdexamfetamine Dimesylate Open-Label, Single-Centre, Phase I Study in Healthy Adult Volunteers
Suma M. Krishnan et al.
CLINICAL DRUG INVESTIGATION (2008)
Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
Robert L. Findling et al.
CNS SPECTRUMS (2008)
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
Lenard A. Adler et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Fast uptake and long-lasting binding of methamphetamine in the human brain: Comparison with cocaine
Joanna S. Fowler et al.
NEUROIMAGE (2008)
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD
D. J. Heal et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: A secondary analysis
Frank A. Lopez et al.
POSTGRADUATE MEDICINE (2008)
Trafficking of vesicular neurotransmitter transporters
Hao Fei et al.
TRAFFIC (2008)
isdexamfetamine dimesylate for childhood ADHD
Vishal Madaan
DRUGS OF TODAY (2008)
Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003
Moupali Das-Douglas et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2008)
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study
Joseph Biederman et al.
BIOLOGICAL PSYCHIATRY (2007)
Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo
Nimish Sidhpura et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats
M. Pum et al.
PSYCHOPHARMACOLOGY (2007)
Adderall® produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers
B. Matthew Joyce et al.
PSYCHOPHARMACOLOGY (2007)
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
Joseph Biederman et al.
CLINICAL THERAPEUTICS (2007)
Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission
P. Bredeloux et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain
Neil Easton et al.
NEUROPHARMACOLOGY (2007)
Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat
Chad J. Swanson et al.
NEUROPHARMACOLOGY (2006)
A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder
J Biederman et al.
CLINICAL THERAPEUTICS (2006)
An interim analysis of the quality of life, effectiveness, safety, and tolerability (QUEST) evaluation of mixed amphetamine salts extended release in adults with ADHD
DW Goodman et al.
CNS SPECTRUMS (2005)
Rodent models of attention-deficit/hyperactivity disorder
T Sagvolden et al.
BIOLOGICAL PSYCHIATRY (2005)
Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD
WE Pelham et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2005)
Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core
PEA Glaser et al.
PSYCHOPHARMACOLOGY (2005)
Animal models of attention-deficit hyperactivity disorder
Vivienne A. Russell et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2005)
Methylphenidate improves prefrontal cortical cognitive function through alpha 2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder
Amy F. T. Arnsten et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2005)
Differential interactions of desipramine with amphetamine and methamphetamine: Evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex
JR Shoblock et al.
NEUROCHEMICAL RESEARCH (2004)
A pharmacokinetic/pharmacodynamic study comparing a single morning dose of Adderall to twice-daily dosing in children with ADHD
LL Greenhill et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2003)
Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine:: a dual-probe microdialysis study in rat frontal cortex and hypothalamus
SM Géranton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Neurochemical and behavioral differencet between d-methamphetamine and d-amphetamine in rats
JR Shoblock et al.
PSYCHOPHARMACOLOGY (2003)
Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD
ND Volkow et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
A review of the biological bases of ADHD: What have we learned from imaging studies?
S Durston
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2003)
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in Attention Deficit/Hyperactivity Disorder
FP Bymaster et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine
R Tao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat
MS Mazei et al.
BRAIN RESEARCH (2002)
Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD
RS James et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2001)
Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD)
T Sagvolden
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)
Share Paper
